Refine your search

Content type
Tags
Firm name
Author
Jurisdiction
Language

1,248 results found

Article
Ask Lexy

Bird & Bird LLP | European Union, Italy | 5 Oct 2021

Year in review: notable 2020 Patent Cases in Italy

The Supreme Court held that prosecution history estoppel has no legal basis in the Italian patent law system. The assessment of patent infringement…
Article
Ask Lexy

Edgeworth Economics | USA | 24 Jul 2020

Lamictal and the Myth of “Generic” “Pay-for-Delay” Cases

On April 22, 2020, the US Court of Appeals for the Third Circuit overturned a district court decision certifying a class of direct purchaser…
Article
Ask Lexy

Loeb & Loeb LLP | USA | 9 Jan 2020

Teva Sales and Marketing Inc. Settlement Agreement

Teva Sales and Marketing Inc, (a subsidiary of Teva Pharmaceuticals) agreed Dec. 28, 2019, to pay $54 million to resolve claims brought by two…
Article
Ask Lexy

S Horowitz & Co | Israel | 22 Jul 2019

Not worth its salt: Merck's patent application covering JANUVIA® does not survive Teva's opposition

In a decision rendered earlier this month, the Deputy Commissioner of Patents, Jacqueline Bracha, allowed an opposition filed by Teva…
Article
Ask Lexy

Dilworth IP | USA | 7 May 2019

Pain Treatment, Kidney Failure, and §101

In Endo Pharmaceuticals Inc. v. Teva the Federal Circuit has further clarified the patent eligibility of treatment methods which include natural…
Article
Ask Lexy

Harness, Dickey & Pierce, PLC | USA | 30 Apr 2019

Prior User Defense Protects Trade Secret Owners Whose Secret is Patented by Another

The inventor of new technology has two choices for protection: patents or trade secrets. They are generally mutually exclusive, because the…
Article
Ask Lexy

DLA Piper | USA | 11 Apr 2019

Supreme Court Corner Q1 2019

In celebration of the 10th anniversary of IPT News, we note that 10 years ago, in the first quarter of 2009, Bernard L. Bilski filed his petition in…
Article
Ask Lexy

Bird & Bird LLP | United Kingdom | 27 Mar 2019

Supreme Court holds Dosage Regime Patent Obvious

Today in Actavis v ICOS the Supreme Court unanimously ruled that the ICOS patent for a Tadalafil dosing regime was invalid. Lord Hodge gave the only…
Article
Ask Lexy

Dilworth IP | USA | 12 Mar 2019

Use Your Calendar & Confidentiality to Protect the Next Big Idea

In January, the Supreme Court issued a ruling on how the commercial life of a new product can become fatal to the possibility of obtaining a patent…
Article
Ask Lexy

Ehrlich Group | USA | 16 Feb 2019

US Supreme Court: Secret Sale of an Invention May Qualify as Prior art under AIA

In Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. dated January 22, 2019, The United States Supreme Court unanimously held that the sale of…
Previous page 1 2 3 ...